抗脂综合征中血小板板板素1通道的原血栓激活
Bruna de Moraes Mazetto Fonseca1,2, Somanathapura K NaveenKumar1, Srilakshmi Yalavarthi1
1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
板素-1 (PANX1) 通道有助于抗脂综合征 (APS) 中的血小板激活. 阻止PANX1可能有助于在不影响正常血液凝固的情况下控制APS患者的血栓形成.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 血栓形成研究研究
背景情况:
- 血小板激活涉及通过脱粒和pannexin-1 (PANX1) 通道的细胞外ATP释放.
- 激活的ATP与P2X受体结合,通过信号放大血小板激活.
- 抗脂综合征 (APS) 是一种由血小板激活抗脂抗体驱动的血栓炎症疾病.
研究的目的:
- 研究血小板PANX1通道在抗脂综合征 (APS) 病理生理学的作用.
- 评估PANX1抑制对APS患者血小板激活标志物的影响.
主要方法:
- 从APS患者 (n=36),全身性红斑狼患者 (n=10) 和健康对照组 (n=16) 中分离了血小板.
- 测量了细胞外ATP释放,血小板信号传递,P-选择素暴露和聚合.
- 使用PANX1抑制剂卡本诺克索隆来评估其对血小板激活的影响.
主要成果:
- 与对照组相比,来自APS患者的血小板表现出明显更高的基底ATP释放.
- 碳醇治疗使ATP释放正常化,并降低了APS血小板中的P-选择蛋白表达.
- 在APS患者中,IgG增强了PANX1酸化和ATP释放,而这种释放被carbenoxolone抑制.
- 阻断P2X1受体或结合降低了APS IgG诱导的血小板激活.
结论:
- 血小板PANX1通道是APS中血小板过活化的关键媒介.
- 抑制PANX1通道显示出恢复血小板稳态和减少APS中血栓形成的潜力.
- 向PANX1可能为APS提供治疗策略,可能不会影响血液静止.
更多相关视频
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Peripheral Artery Disease I: Introduction
Clot Retraction and Fibrinolysis
